Amy Pointon

1.5k total citations
35 papers, 1.1k citations indexed

About

Amy Pointon is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Amy Pointon has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Cardiology and Cardiovascular Medicine and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Amy Pointon's work include Cardiac electrophysiology and arrhythmias (15 papers), Receptor Mechanisms and Signaling (8 papers) and Pluripotent Stem Cells Research (7 papers). Amy Pointon is often cited by papers focused on Cardiac electrophysiology and arrhythmias (15 papers), Receptor Mechanisms and Signaling (8 papers) and Pluripotent Stem Cells Research (7 papers). Amy Pointon collaborates with scholars based in United Kingdom, Sweden and United States. Amy Pointon's co-authors include Najah Abi‐Gerges, Michael Cross, James E. Sidaway, Christopher E. Pollard, C Archer, James Pilling, Christina Schindler, Tristan J. Vaughan, Ralph Minter and Natalie J. Tigue and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Amy Pointon

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Pointon United Kingdom	15	598	382	303	185	156	35	1.1k
Chrishan J. A. Ramachandra Singapore	20	830 1.4×	165 0.4×	385 1.3×	120 0.6×	179 1.1×	46	1.4k
Mehmet G. Badur United States	10	732 1.2×	138 0.4×	47 0.2×	70 0.4×	158 1.0×	10	1.1k
Cathy Malcontenti‐Wilson Australia	16	250 0.4×	92 0.2×	95 0.3×	31 0.2×	139 0.9×	32	802
Chaochu Cui China	10	686 1.1×	108 0.3×	42 0.1×	63 0.3×	61 0.4×	21	1.1k
Weiwei An China	21	694 1.2×	188 0.5×	49 0.2×	53 0.3×	84 0.5×	31	1.2k
Michelle M. Monasky Italy	21	704 1.2×	50 0.1×	889 2.9×	89 0.5×	89 0.6×	59	1.3k
Mihail I. Mitov United States	15	545 0.9×	145 0.4×	133 0.4×	20 0.1×	68 0.4×	26	1.0k
Neil MacRitchie United Kingdom	18	466 0.8×	148 0.4×	121 0.4×	16 0.1×	101 0.6×	27	1.1k
Ronald J. Holewinski United States	22	833 1.4×	64 0.2×	437 1.4×	38 0.2×	73 0.5×	41	1.3k

Countries citing papers authored by Amy Pointon

Since Specialization

Citations

This map shows the geographic impact of Amy Pointon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Pointon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Pointon more than expected).

Fields of papers citing papers by Amy Pointon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Pointon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Pointon. The network helps show where Amy Pointon may publish in the future.

Co-authorship network of co-authors of Amy Pointon

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Pointon. A scholar is included among the top collaborators of Amy Pointon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Pointon. Amy Pointon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meleckyte, Ruta, Jasmin Zohren, Tania Incitti, et al.. (2025). A human induced pluripotent stem cell toolbox for studying sex chromosome effects. Stem Cell Reports. 20(11). 102678–102678. 1 indexed citations

Hall, Andrew, Andrew D. Southam, Ralf J. M. Weber, et al.. (2025). Mass spectrometry-based characterisation of the cardiac microtissue metabolome and lipidome. Metabolomics. 21(3). 54–54.

Obrezanova, Olga, Jiarui Zhou, Delyan P. Ivanov, et al.. (2024). Computational approaches identify a transcriptomic fingerprint of drug-induced structural cardiotoxicity. Cell Biology and Toxicology. 40(1). 50–50. 4 indexed citations

Starnes, Linda M., et al.. (2024). RYR2 deficient human model identifies calcium handling and metabolic dysfunction impacting pharmacological responses. Frontiers in Cardiovascular Medicine. 11. 1357315–1357315. 2 indexed citations

Morris, Christopher J., Michael G. Rolf, Linda M. Starnes, et al.. (2024). Modelling hemodynamics regulation in rats and dogs to facilitate drugs safety risk assessment. Frontiers in Pharmacology. 15. 1402462–1402462.

Koukorava, Chrysa, et al.. (2024). Anticancer drugs and cardiotoxicity: the role of cardiomyocyte and non-cardiomyocyte cells. Frontiers in Cardiovascular Medicine. 11. 1372817–1372817. 6 indexed citations

Southam, Andrew D., Andrew Hall, Ralf J. M. Weber, et al.. (2023). Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomics. Nature Communications. 14(1). 4653–4653. 14 indexed citations

Yang, Hongbin, Amy Pointon, Olga Obrezanova, et al.. (2022). Deriving waveform parameters from calcium transients in human iPSC-derived cardiomyocytes to predict cardiac activity with machine learning. Stem Cell Reports. 17(3). 556–568. 12 indexed citations

Hall, Andrew, Gavin R. Lloyd, Ralf J. M. Weber, et al.. (2021). An Extensive Metabolomics Workflow to Discover Cardiotoxin-Induced Molecular Perturbations in Microtissues. Metabolites. 11(9). 644–644. 4 indexed citations

10.

Guo, Fei, Andrew Hall, Christopher J. Tape, Stephanie Ling, & Amy Pointon. (2021). Intra- and intercellular signaling pathways associated with drug-induced cardiac pathophysiology. Trends in Pharmacological Sciences. 42(8). 675–687. 1 indexed citations

11.

Rolf, Michael G., et al.. (2020). Current and future approaches to nonclinical cardiovascular safety assessment. Drug Discovery Today. 25(7). 1129–1134. 4 indexed citations

12.

McAleer, Christopher W., Amy Pointon, Christopher J. Long, et al.. (2019). On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships. Scientific Reports. 9(1). 9619–9619. 71 indexed citations

13.

Schindler, Christina, Amy Pointon, Lesley Jenkinson, et al.. (2019). Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency. PLoS ONE. 14(3). e0214545–e0214545. 161 indexed citations

14.

Archer, C, et al.. (2018). Characterization and Validation of a Human 3D Cardiac Microtissue for the Assessment of Changes in Cardiac Pathology. Scientific Reports. 8(1). 10160–10160. 99 indexed citations

15.

Pointon, Amy, et al.. (2018). Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity. Drug Metabolism and Disposition. 46(8). 1053–1065. 53 indexed citations

16.

Pointon, Amy, James Pilling, Thierry Dorval, et al.. (2016). From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery. Toxicological Sciences. 155(2). 444–457. 56 indexed citations

17.

Pointon, Amy, et al.. (2016). Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues. Toxicological Sciences. 152(1). 99–112. 94 indexed citations

18.

Pointon, Amy, Tracy Walker, Jinli Luo, et al.. (2010). Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation. PLoS ONE. 5(9). e12733–e12733. 110 indexed citations

19.

Solyakov, Lev, Emre Sayan, Joan Riley, Amy Pointon, & Andrew B. Tobin. (2009). Regulation of p53 expression, phosphorylation and subcellular localization by a G-protein-coupled receptor. Oncogene. 28(41). 3619–3630. 11 indexed citations

20.

Gant, Timothy W., Ursula Lutz, Joel D. Parry, et al.. (2009). Two electron reduction of 2,3-dimethoxy-1,4-naphthoquinone metabolism in vivo prevents redox stress but interaction with the electron transport chain may be a mechanism of toxicity. Toxicology Letters. 189. S119–S119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact